Resource

CASE STUDY

Virtual Biomarker Staining Unlocks the Lung Tumor Microenvironment

Background:
The composition and spatial organization of immune, stromal, and tumor cell populations within the tumor microenvironment (TME) play a central role in modern drug discovery, including target validation, mechanism-of-action studies, combination therapy rationale, and biomarker hypotheses for patient stratification. However, characterizing the TME at scale remains a major bottleneck. Conventional chromogenic IHC requires a separate tissue section for each biomarker, while multiplex immunofluorescence, although capable of measuring several markers on a single slide, remains difficult and costly to scale across large sample sets because it requires extensive panel optimization, complex staining and imaging workflows, management of batch variability and autofluorescence, and substantial quality-control and image-analysis efforts. As research questions increasingly require several biomarkers to be evaluated together, these constraints limit panel breadth and consume tissue that is often scarce or irreplaceable.